Paper37870
Improved physical performance as a therapeutic objective in patients with angina.
Ling AS and 1 other. Br J Clin Pharmacol, 1979. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Improved physical performance as a therapeutic objective in patients with angina. Papers, record 37870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37870
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Angina Pectoris | Major topic |
| Propanolamines | Major topic |
| Propranolol | Major topic |
| Adult | |
| Aged | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Work Capacity Evaluation |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,562 | Treatment of angina pectoris. Pharmacologic approaches. | Postgrad Med | 1976 | https://conductscience.org/library/papers/10562 | PubMed |
| 2 | 10,600 | The clinical pharmacology of beta-adrenoceptor-blocking drugs. | Prog Cardiovasc Dis | 1976 | https://conductscience.org/library/papers/10600 | PubMed |
| 3 | 1,094,291 | Drug therapy: Propranolol. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1094291 | PubMed |
| 4 | 1,256,530 | Hypertension and compliance: implications for the primary physician. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1256530 | PubMed |
| 5 | 13,887,414 | Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide). | Lancet | 1962 | https://conductscience.org/library/papers/13887414 | PubMed |
| 6 | 14,132,613 | A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. | Lancet | 1964 | https://conductscience.org/library/papers/14132613 | PubMed |
| 7 | 16,040 | Metabolic studies in patients with nadolol: oral and intravenous administration. | J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/16040 | PubMed |
| 8 | 191,753 | Myocardial ischemia (first of three parts). | N Engl J Med | 1977 | https://conductscience.org/library/papers/191753 | PubMed |
| 9 | 241,655 | Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. | Eur J Pharmacol | 1975 | https://conductscience.org/library/papers/241655 | PubMed |
| 10 | 406,767 | The management of the patient with angina. | Am Heart J | 1977 | https://conductscience.org/library/papers/406767 | PubMed |
| 11 | 4,202,577 | Exercise tolerance and physical training of non-selected patients after myocardial infarction. | Acta Med Scand Suppl | 1973 | https://conductscience.org/library/papers/4202577 | PubMed |
| 12 | 4,397,655 | Comparison of adrenergic beta-blocking drugs in angina pectoris. | Br Med J | 1971 | https://conductscience.org/library/papers/4397655 | PubMed |
| 13 | 4,405,104 | Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. | Clin Pharmacol Ther | 1973 | https://conductscience.org/library/papers/4405104 | PubMed |
| 14 | 4,635,437 | Some comments and reflections on changing interests and new developments in angina pectoris. | Circulation | 1972 | https://conductscience.org/library/papers/4635437 | PubMed |
| 15 | 5,041,658 | Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. | J Pharmacol Exp Ther | 1972 | https://conductscience.org/library/papers/5041658 | PubMed |
| 16 | 6,243 | Clinical pharmacokinetics of beta-adrenoreceptors blockers. | Drugs | 1976 | https://conductscience.org/library/papers/6243 | PubMed |
| 17 | 787,954 | Propranolol in the treatment of angina: a review. | Postgrad Med J | 1976 | https://conductscience.org/library/papers/787954 | PubMed |
| 18 | 934,973 | Factors influencing the choice of antihypertensive agents. | Postgrad Med | 1976 | https://conductscience.org/library/papers/934973 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,137,236 | Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes. | Br J Ophthalmol | 1983 | https://conductscience.org/library/papers/6137236 | PubMed |
| 6,105,067 | Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. | Drugs | 1980 | https://conductscience.org/library/papers/6105067 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37870
GET https://conductscience.org/api/papers/v1/37870/authors